Murphy Highlights Kleo Pharmaceuticals as 'Murphy's Innovator of the Month'
August 07, 2019
August 07, 2019
WASHINGTON, Aug. 7 -- Sen. Christopher Murphy, D-Connecticut, issued the following news release:
U.S. Senator Chris Murphy (D-Conn.) announced on Wednesday that Kleo Pharmaceuticals, an immuno-oncology company, has been named "Innovator of the Month." The company focuses on developing innovative bispecific compounds designed to emulate or enhance the activity of biologics to directly engage a patient's immune system to target and destroy harmful cells. This work to transla . . .
U.S. Senator Chris Murphy (D-Conn.) announced on Wednesday that Kleo Pharmaceuticals, an immuno-oncology company, has been named "Innovator of the Month." The company focuses on developing innovative bispecific compounds designed to emulate or enhance the activity of biologics to directly engage a patient's immune system to target and destroy harmful cells. This work to transla . . .